Paul Hartmann AG (PHH2) - Total Liabilities

Latest as of December 2025: €938.79 Million EUR ≈ $1.10 Billion USD

Based on the latest financial reports, Paul Hartmann AG (PHH2) has total liabilities worth €938.79 Million EUR (≈ $1.10 Billion USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Paul Hartmann AG long-term investment allocation to see how much of total assets are deployed in long-term investments.

Paul Hartmann AG - Total Liabilities Trend (2013–2025)

This chart illustrates how Paul Hartmann AG's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see PHH2 total assets.

Paul Hartmann AG Competitors by Total Liabilities

The table below lists competitors of Paul Hartmann AG ranked by their total liabilities.

Company Country Total Liabilities
Guilin Layn Natural Ingredients Corp
SHE:002166
China CN¥1.85 Billion
PennyMac Mortgage Investment Trust
NYSE:PMT
USA $19.46 Billion
PSI Software AG
F:PSAN
Germany €227.15 Million
Dilip Buildcon Limited
NSE:DBL
India Rs144.99 Billion
V V Food & Beverage Co Ltd
SHG:600300
China CN¥1.11 Billion
Dalian Demaishi Precision Technology Co.Ltd
SHE:301007
China CN¥424.15 Million
CyberPower Systems Inc
TW:3617
Taiwan NT$5.86 Billion
Suprajit Engineering Limited
NSE:SUPRAJIT
India Rs16.83 Billion

Liability Composition Analysis (2013–2025)

This chart breaks down Paul Hartmann AG's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Paul Hartmann AG (PHH2) balance sheet quality index to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 2.22 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.80 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.43 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Paul Hartmann AG's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Paul Hartmann AG (2013–2025)

The table below shows the annual total liabilities of Paul Hartmann AG from 2013 to 2025.

Year Total Liabilities Change
2025-12-31 €938.79 Million
≈ $1.10 Billion
+4.10%
2024-12-31 €901.80 Million
≈ $1.05 Billion
+3.51%
2023-12-31 €871.24 Million
≈ $1.02 Billion
-0.75%
2022-12-31 €877.81 Million
≈ $1.03 Billion
+19.91%
2021-12-31 €732.05 Million
≈ $855.85 Million
-3.32%
2020-12-31 €757.19 Million
≈ $885.23 Million
+11.85%
2019-12-31 €676.95 Million
≈ $791.43 Million
+17.49%
2018-12-31 €576.16 Million
≈ $673.59 Million
-0.17%
2017-12-31 €577.13 Million
≈ $674.73 Million
+12.47%
2016-12-31 €513.13 Million
≈ $599.90 Million
-1.23%
2015-12-31 €519.52 Million
≈ $607.37 Million
-6.70%
2014-12-31 €556.83 Million
≈ $650.99 Million
+3.17%
2013-12-31 €539.74 Million
≈ $631.01 Million
--

About Paul Hartmann AG

F:PHH2 Germany Medical Instruments & Supplies
Market Cap
$826.32 Million
€706.80 Million EUR
Market Cap Rank
#10474 Global
#1228 in Germany
Share Price
€199.00
Change (1 day)
+0.25%
52-Week Range
€197.00 - €232.00
All Time High
€376.24
About

Paul Hartmann AG manufactures and sells medical and care products in Germany, the rest of Europe, the Middle East, Africa, Asia and Pacific region, and the Americas. The company operates through three segments: Wound Care, Incontinence Management, and Infection Management. It offers absorbent underwear, incontinence pads and pants, and fixation pants; medical skincare products; wound management p… Read more